CMS provided the new updates ahead of the annual Medicare Open Enrollment period, scheduled from October 15, 2025, to ...

But plans can remove medications from their drug lists, add prior authorization restrictions and even increase deductibles ...

The Centers for Medicare & Medicaid Services (CMS) announced on Friday that Medicare Advantage (MA) and Medicare Part D ...

Medicare Part D coverage of glucagon-like peptide-1 receptor agonists— widely prescribed for diabetes and increasingly sought for obesity and related conditions— has remained broad. A research letter ...

Medicare Advantage premiums will decrease slightly next year, with the average monthly premium across all MA coverage projected to be $14, down from $16.40 in 2025, according to the Centers for ...

Medicare Part D covers prescription drugs for millions of Americans. By 2025, annual out-of-pocket expenses will be capped at $2,000, offering greater financial protection.

Medicare beneficiaries face higher premiums and deductibles, reduced services, and possible cuts to the program at large—but ...

Starting October 1, the U.S. is taking a hard stance on pharmaceutical manufacturing: Imported brand-name, patented drugs ...

Sweeping changes over the past few years to Medicare Part D will continue in 2026, with insurers recalibrating offerings to ...

Certain parts of Medicare may cover medications like Kisqali. However, there are still out-of-pocket costs. Medicare Part D helps cover prescription drugs, like Kisqali. If a person has Original ...